1Semssn A,Munkarah AR,Arabi H. Expression of GLUT-1 in epithelial ovarian carcinoma:correlation with tumor cell proliferation,angiogenesis,survival and ability to predict operdict cytoreduction[J].Gynecdl Oncol,2011,(01):181.
2Nielsen TO,Hsu FD,Jensen K. lmmunohis to chemical and clinical charact erizati on of the basal-like subtype of invasive breast carcinoma[J].Clinical Cancer Research,2004,(06):5367.
3Cooper R,Sarioglu S,Sokmen. Glucose transporter-l(GLUT-1):a potential marker of prognosis in rectal carcinoma[J].British Journal of Cancer,2003,(05):870.
4Parkin D M,Bray F,Ferloy. Global cancer,statistics[J].CA:A Cancer Journal for Clinicians,2005,(02):74.
5Eckert A W,Lautner M H,Taubert H. Expression of GLUT-1 is a prognostic marter of orol squamous cell carcinoma patints[J].Oncology Reports,2008,(06):1381.
2Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. JPN J Cancer Res,2002;93(10):1123-1128.
3Stackhouse BL, Williams H, Berry P, etal. Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Tr,2005 ;93(3):247-253.
4Zamora-Leon SP, Golde DW, Concha II, et al. Expression of the fructose transporter GLUTS in human breast cancer. Proc Natl Acad Sci USA,1996,93(5) :1847-1852.
5Gatenby RA, Gillies RJ. Why do cancers have high aerobic glyeolysis? Nat Rev Cancer,2004,4(11) :891-899.
6Stubbs M, Bashford CL, Griffiths JR. Understanding the tumor metabolic phenotype in the genom~c era. Curr Mol Med, 2003;3(1) :49-59.
7Maria L, Mached A, Suzanne R, etal. Molecular and cellular regulation of glucose tranporter(GLUT) protein in cnacer. J Cell Physiol,2005,202(3) :654-662.
8Rivenzon-Segal D, Boldin-Adamsky S, SegerD, et al. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer, 2003, 107(2):177-182.
9Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol, 2002, 20 (2) : 379-387.
10Ito S, Fukusato T, Nemoto T, et al. Coexpression of glucose tranporter 1 and matrix metalloproteinase-2 in human cancers. J Natl Caneer Inst,2002,94(14):1080-1091.
